Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 EUR | -1.64% | -5.71% | -16.67% |
04-05 | Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Biotechnology Assets, S.A. Auditor Raises 'Going Concern' Doubt | CI |
Business Summary
Number of employees: 37
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Research and Development Services
98.0
%
| 3 | 99.8 % | 3 | 98.0 % | -16.80% |
Other
2.0
%
| 0 | 0.2 % | 0 | 2.0 % | +717.90% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Europe
76.7
%
| 2 | 76.6 % | 2 | 76.7 % | +0.75% |
Americas
23.3
%
| 1 | 23.3 % | 1 | 23.3 % | +0.32% |
Middle East
0.1
%
| 0 | 0.1 % | 0 | 0.1 % | +1.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 60 | 19-10-31 | |
Javier Uría
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 06-12-31 | |
Chief Tech/Sci/R&D Officer | 57 | 19-03-31 | |
Sales & Marketing | - | - | |
Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Director/Board Member | - | - | |
John Dixon
BRD | Director/Board Member | 68 | - |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,858,651 | 35,780,137 ( 56.03 %) | 121,169 ( 0.1897 %) | 56.03 % |
Company contact information
Biotechnology Assets SA
Avenida del Desarrollo Tecnológico nº 11
11591, Jerez de la Frontera
+
http://www.adlbionatur.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-16.67% | 22.46M | |
+16.49% | 122B | |
+21.73% | 115B | |
+22.82% | 26.64B | |
-21.81% | 19.91B | |
-17.01% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- BST Stock
- Company Biotechnology Assets, S.A.